Tata Chemicals Limited has informed the Exchange regarding a press release dated May 07, 2025, titled "Audited Consolidated and Standalone Financial Results of the Company for the quarter and financial year ended March 31, 2025".
TATACHEM · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Tata Chemicals reported Q4FY25 consolidated revenue of ₹3,509 Cr, up 1% YoY, but EBITDA fell sharply to ₹327 Cr from ₹443 Cr a year ago due to pricing pressure across all geographies. The company slipped into a small loss at the PAT level (₹(12) Cr vs ₹145 Cr profit in Q4FY24), partly hit by a ₹55 Cr exceptional charge from shutting down its Soda Ash unit in Lostock, UK. For the full year FY25, consolidated revenue declined to ₹14,887 Cr from ₹15,421 Cr in FY24, while EBITDA dropped to ₹1,953 Cr from ₹2,847 Cr, with an overall exceptional charge of ₹125 Cr linked to the UK plant closure. The company commissioned new capacity (230kT Soda Ash and 140kT Bicarb in India; 70kT Pharma Grade Salt in UK) and the Board recommended a dividend of ₹11 per share. Gross debt rose by ₹1,509 Cr to ₹7,072 Cr due to higher working capital needs in India, US, and UK.
Negative for short-term sentiment — sharp fall in profits and EBITDA despite revenue stability signals margin pressure and weak pricing power. Plant closure in UK and rising debt are concerns, but new capacity additions, a maintained dividend, and improving standalone working capital offer some support for medium-term outlook.